Cargando…

NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells

Cervical cancer is one of the most common female malignancies, and cisplatin-based chemotherapy is routinely utilized in locally advanced cervical cancer patients. However, resistance has been the major limitation. In this study, we found that Na(+)/H(+) Exchanger Regulatory Factor 1 (NHERF1) was do...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Tao, Yang, Xiaomei, Qin, Qiong, Shi, Wen, Wang, Qiqi, Yang, Ying, He, Junqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297640/ https://www.ncbi.nlm.nih.gov/pubmed/28085111 http://dx.doi.org/10.3390/ijms18010005

Ejemplares similares

NHERF1 inhibits beta-catenin-mediated proliferation of cervical cancer cells through suppression of alpha-actinin-4 expression
por: Wang, Qiqi, et al.
Publicado: (2018)

NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer
por: Meng, Ran, et al.
Publicado: (2016)

NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway
por: Gu, Yanan, et al.
Publicado: (2016)

Roles for NHERF1 and NHERF2 on the Regulation of C3a Receptor Signaling in Human Mast Cells
por: Subramanian, Hariharan, et al.
Publicado: (2012)

Enhancement of Cisplatin Sensitivity in Human Cervical Cancer: Epigallocatechin-3-Gallate
por: Kilic, Ulkan, et al.
Publicado: (2015)

Two Enhances the Cisplatin Sensitivity of Cervical Cancer Cells via Suppression of c-MET Expression
por: Chen, Ziqin, et al.
Publicado: (2023)

The NHERF2 sequence adjacent and upstream of the ERM-binding domain affects NHERF2–ezrin binding and dexamethasone stimulated NHE3 activity
por: Yang, Jianbo, et al.
Publicado: (2015)

HPV16 Impacts NHERF2 Expression in Oropharyngeal Cancers
por: Lulić, Lucija, et al.
Publicado: (2023)

SIP1/NHERF2 enhances estrogen receptor alpha transactivation in breast cancer cells
por: Meneses-Morales, Ivan, et al.
Publicado: (2014)

The Biological Relevance of NHERF1 Protein in Gynecological Tumors
por: Sonnessa, Margherita, et al.
Publicado: (2022)

Intestinal Gastrin/CCKBR (Cholecystokinin B Receptor) Ameliorates Salt-Sensitive Hypertension by Inhibiting Intestinal Na(+)/H(+) Exchanger 3 Activity Through a PKC (Protein Kinase C)-Mediated NHERF1 and NHERF2 Pathway
por: Jiang, Xiaoliang, et al.
Publicado: (2022)

Nuclear NHERF1 expression as a prognostic marker in breast cancer
por: Paradiso, A, et al.
Publicado: (2013)

NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings()
por: Centonze, Matteo, et al.
Publicado: (2018)

Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Lung Cancer Cells and Inhibits Regulating Epithelial-to-Mesenchymal Transition
por: Liu, Shenggang, et al.
Publicado: (2016)

Multisite NHERF1 phosphorylation controls GRK6A regulation of hormone-sensitive phosphate transport
por: Vistrup-Parry, Maria, et al.
Publicado: (2021)

NHERF2 is crucial in ERM phosphorylation in pulmonary endothelial cells
por: Boratkó, Anita, et al.
Publicado: (2013)

NHERF1: molecular brake on the PI3K pathway in breast cancer
por: Georgescu, Maria-Magdalena
Publicado: (2008)

Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients
por: Schirosi, Laura, et al.
Publicado: (2019)

CFTR-NHERF2-LPA(2) Complex in the Airway and Gut Epithelia
por: Zhang, Weiqiang, et al.
Publicado: (2017)

Bixin and fucoxanthin sensitize human lung cancer and cervical cancer cell to cisplatin in vitro
por: Nurcahyanti, Agustina Dwi Retno, et al.
Publicado: (2021)

Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer
por: Takekuma, Munetaka, et al.
Publicado: (2015)

Repression of metadherin inhibits biological behavior of prostate cancer cells and enhances their sensitivity to cisplatin
por: WEI, YONG-BAO, et al.
Publicado: (2015)

Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling
por: Wheeler, David S., et al.
Publicado: (2010)

NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma
por: Saponaro, Concetta, et al.
Publicado: (2018)

NHERF1 Loss Upregulates Enzymes of the Pentose Phosphate Pathway in Kidney Cortex
por: Bushau-Sprinkle, Adrienne, et al.
Publicado: (2020)

Ghrelin enhances cisplatin sensitivity in HO-8910 PM human ovarian cancer cells
por: Leng, Yun, et al.
Publicado: (2021)

Pentoxifylline Sensitizes Cisplatin-Resistant Human Cervical Cancer Cells to Cisplatin Treatment: Involvement of Mitochondrial and NF-Kappa B Pathways
por: Bravo-Cuellar, Alejandro, et al.
Publicado: (2020)

Silencing RIF1 decreases cell growth, migration and increases cisplatin sensitivity of human cervical cancer cells
por: Mei, Ying, et al.
Publicado: (2017)

Suppression of breast cancer cell growth by Na(+)/H(+ )exchanger regulatory factor 1 (NHERF1)
por: Pan, Yong, et al.
Publicado: (2006)

β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients
por: Schirosi, Laura, et al.
Publicado: (2016)

Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells
por: Huang, Wei, et al.
Publicado: (2016)

PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma
por: Molina, Jennifer R., et al.
Publicado: (2011)

NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors
por: Georgescu, Maria-Magdalena, et al.
Publicado: (2016)

NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma
por: Georgescu, Maria-Magdalena, et al.
Publicado: (2015)

New Conformational State of NHERF1-CXCR2 Signaling Complex Captured by Crystal Lattice Trapping
por: Jiang, Yuanyuan, et al.
Publicado: (2013)

Targeting phosphodiesterase 3B enhances cisplatin sensitivity in human cancer cells
por: Uzawa, Katsuhiro, et al.
Publicado: (2013)

Reduced MAGI3 level by HPV18E6 contributes to Wnt/β‐catenin signaling activation and cervical cancer progression
por: Yang, Zhuoli, et al.
Publicado: (2021)

SETD8, a frequently mutated gene in cervical cancer, enhances cisplatin sensitivity by impairing DNA repair
por: Wang, Xin, et al.
Publicado: (2023)

EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
por: Wang, Xuemin, et al.
Publicado: (2015)

Astragaloside IV Enhances Cisplatin Chemosensitivity in Human Colorectal Cancer via Regulating NOTCH3
por: Xie, Tao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_feummbg7mg17alg7k2ns5ikkt6